Related Experiment Video

Updated: May 21, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

[Thyroid tumors--moleculargenetic causes and choices for target therapy]

Bendlová Bela1, Dvoráková Sárka, Sýkorová Vlasta

  • 1Endokrinologický ústav Praha, Oddelení molekulární endokrinologie. bbendlova@endo.cz

Casopis Lekaru Ceskych
|June 12, 2012
PubMed

Insights

Thyroid tumors, the most common endocrine cancer, are linked to specific genetic mutations. Understanding these genetic causes is crucial for developing targeted gene therapies and personalized treatments.

Area of Science:

  • Endocrinology
  • Oncology
  • Genetics

Background:

  • Thyroid tumors represent the most frequent endocrine malignancy.
  • Key genetic alterations include RET proto-oncogene mutations in medullary thyroid carcinoma.
  • BRAF, RAS mutations, and RET/PTC rearrangements are implicated in follicular cell-derived carcinomas.

Purpose of the Study:

  • To review the primary genetic causes of thyroid tumors.
  • To summarize the application of genetic knowledge in thyroid cancer target gene therapy.
  • To highlight advancements in individualized treatment strategies for thyroid malignancies.

Main Methods:

  • Literature review of genetic alterations in thyroid tumors.
  • Analysis of molecular diagnostic approaches for RET mutations.
  • Examination of current target gene therapy applications in thyroid cancer.

Main Results:

  • Identified specific genetic mutations (RET, BRAF, RAS, RET/PTC) associated with different thyroid tumor types.
  • Established the clinical relevance of moleculargenetic diagnosis for RET mutations in medullary thyroid carcinoma.
  • Demonstrated the emerging role of genetic insights in developing targeted therapies.

Conclusions:

  • Genetic mutations are fundamental to thyroid tumorigenesis.
  • Moleculargenetic diagnosis and targeted gene therapy are transforming thyroid cancer management.
  • Personalized treatment approaches based on genetic profiles are becoming standard practice.

More Related Videos

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...